Patent intelligence · TW
TW 200942531
Crystal forms of a nitrocatechol
Crystal forms of a nitrocatechol
Patent details — TW 200942531
- Jurisdiction
- TW
- Status
- granted
- Grant date
- Oct 16, 2009
- Expiration
- Oct 11, 2029
- Applicant
- BIAL PORTELA & COMPANHIA S A [PT]
- CPC classes
- A61K 31/ 4427 A I, A61P/100, A61P/104, A61P/2500
Quick answer
TW 200942531 (Crystal forms of a nitrocatechol) is held by BIAL PORTELA & COMPANHIA S A [PT]. Status: granted. Granted Oct 16, 2009. Expires Oct 11, 2029 (3 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BIAL PORTELA & COMPANHIA S A [PT]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 31/ 4427 A I, A61P/100, A61P/104, A61P/2500, A61P/2502, A61P/2516
More from BIAL PORTELA & COMPANHIA S A [PT]
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 200942531?
TW 200942531 (Crystal forms of a nitrocatechol) is held by BIAL PORTELA & COMPANHIA S A [PT]. Status: granted. Granted Oct 16, 2009. Expires Oct 11, 2029 (3 years remaining) — relevant for patent-cliff and LOE planning.
Who owns TW 200942531?
BIAL PORTELA & COMPANHIA S A [PT] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 3 pharmaceutical patents for this assignee.
When does TW 200942531 expire?
Our index shows an expiration date of Oct 11, 2029 (3 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.